These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Muqit MM; Saidkasimova S; Keating D; Murdoch JR Acta Ophthalmol; 2010 May; 88(3):e57-65. PubMed ID: 20222903 [TBL] [Abstract][Full Text] [Related]
27. Central retinal vein occlusion and branch retinal vein occlusion in the same eye. Sundar MD; Puri P; Chawla R; Hasan N Indian J Ophthalmol; 2019 Aug; 67(8):1344. PubMed ID: 31332135 [No Abstract] [Full Text] [Related]
28. Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment. Ueda T; Gomi F; Suzuki M; Sakaguchi H; Sawa M; Kamei M; Nishida K Retina; 2012 Feb; 32(2):308-13. PubMed ID: 21869614 [TBL] [Abstract][Full Text] [Related]
34. [Current therapy of retinal venous obstruction]. Călugăru M Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978; 22(1):57-8. PubMed ID: 653031 [No Abstract] [Full Text] [Related]
35. Cilioretinal artery and central retinal vein occlusion after sildenafil use. Hafidi Z; Handor H; Laghmari M; Daoudi R Emerg Med J; 2014 Jul; 31(7):535. PubMed ID: 23956320 [No Abstract] [Full Text] [Related]
36. Sequential treatment of central retinal vein occlusion with intravitreal tissue plasminogen activator and intravitreal triamcinolone. Lahey JM; Kearney JJ; Cheung MC Br J Ophthalmol; 2004 Aug; 88(8):1100-1. PubMed ID: 15258039 [No Abstract] [Full Text] [Related]
37. Perivenular whitening in central vein occlusion described by fundus autofluorescence and spectral domain optical coherence tomography. Pichi F; Morara M; Veronese C; Lembo A; Nucci P; Ciardella AP Retina; 2012 Jul; 32(7):1438-9. PubMed ID: 22722654 [No Abstract] [Full Text] [Related]
38. Central retinal vessel blood flow after surgical treatment for central retinal vein occlusion. Crama N; Gualino V; Restori M; Charteris DG Retina; 2010; 30(10):1692-7. PubMed ID: 20706174 [TBL] [Abstract][Full Text] [Related]
39. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
40. Reperfusion of large ischemic areas associated with central retinal vein occlusion: a potential novel treatment with activated protein C. Kamei M; Matsumura N; Suzuki M; Sakimoto S; Sakaguchi H; Nishida K JAMA Ophthalmol; 2014 Mar; 132(3):361-2. PubMed ID: 24626830 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]